Oncobiotics in urinary bladder cancer. A narrative review of living cancer therapeutics (LCTs) - Top-Institutions - MDSpire

Oncobiotics in urinary bladder cancer. A narrative review of living cancer therapeutics (LCTs)

  • By

  • Abuhasanein, Suleiman

  • June 22, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, Massachusetts

    Key Differentiators

    • Oncology

Original Source(s)

Oncobiotics in urinary bladder cancer. A narrative review of living cancer therapeutics (LCTs)

  • by Abuhasanein, Suleiman

  • June 22, 2026

Related Content

Current issues in clinical staging of perihilar cholangiocarcinoma—a European snapshot survey

Case Report: Conversion therapy for initially unresectable intrahepatic cholangiocarcinoma

Endocrine-driven inflammatory–epigenetic adaptation as a proposed axis of radioresistance in endocrine-exposed prostate cancer: a translational hypothesis